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We would like to thank Clutterbuck, Harris, and Mobasheri
for their interest in our work and their comments on our
recently published article ‘Comparison between chondro-
protective effects of glucosamine, curcumin, and diacerein
in IL-1ß-stimulated C-28/I2 chondrocytes’1.
In our report, we have demonstrated that glucosamine
and diacerein promote a differentiated chondrocytic pheno-
type of immortalized human C-28/I2 chondrocytes by alter-
ing proliferation, morphology, and collagen type II (COL2)/
collagen type I (COL1) mRNA ratios. Moreover, both agents
antagonized inhibitory effects of IL-1ß by enhancing aggre-
can (AGC) and COL2 as well as by reducing COL1 mRNA
levels. Given the well known differences between immortal-
ized cell lines and primary cells2, it was our aim to assess
the applicability of the C-28/I2 cell line as a model for the
evaluation of chondroprotective action. Interestingly, our
data from C-28/I2 chondrocytes were in line with the major-
ity of in vitro studies in literature suggesting the efﬁciency of
glucosamine and diacerein to promote the chondrocyte
phenotype and to antagonize IL-1ß effects on extracellular
matrix (ECM) components.
In addition, we have observed cytotoxic effects of curcu-
min at 50 mM on C-28/I2 cells. Being aware of this conﬂict-
ing ﬁnding compared to studies on curcumin using primary
chondrocytes, we have discussed this issue in our article
also by citing the work of Mobasheri’s group3. We literally
stated: ‘Interestingly, our ﬁndings are contrary to a recent
study on curcumin regarding the viability of chondrocytes
in response to this agent. Shakibaei et al. reported that
the treatment with 50 mM curcumin for up to 48 h did not af-
fect the viability of primary human chondrocytes at the mi-
croscopic and ultra-structural levels3. In contrast, we
found that this concentration severely damaged the integrity
of the C-28/I2 cell membrane and induced cell detachment
after 24 h incubation. It remains to be clariﬁed whether this
reduced viability in response to 50 mM curcumin represents
a special feature of C-28/I2 cells.’
In their comment on our article, Clutterbuck and
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137that at concentrations between 0.1 mM and 100 mM curcu-
min did not induce toxic effects in a cartilage explant culture
model. They further cite several papers documenting that
curcumin exerts pro-apoptotic effects in cancer cells and
cancer cell lines and hypothesize that the immortalized
C-28/I2 cell line might react in a similar way. In our view,
this may well be an explanation for the inconsistent ﬁndings
regarding the action of curcumin in immortalized and
primary chondrocytes; however, the speciﬁc mechanisms
underlying this effect still remain to be determined.
In summary, we appreciate the constructive remarks of
Clutterbuck and colleagues concerning the cytotoxic effect
of curcumin in C-28/I2 chondrocytes as a pointer toward
explanation of an apparently conﬂicting result.S. Q. Wu, MPharmSy, S. Toegel, MPharmS, Ph.D.yz*
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